These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1723468

  • 21. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 22. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP, Joglekar SJ, Mukherjee S, Nanivadekar AS.
    J Assoc Physicians India; 1998 Apr; Suppl 1():30-40. PubMed ID: 11233385
    [Abstract] [Full Text] [Related]

  • 23. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 24. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
    Piñol C, Cobos A, Cases A, Esmatges E, Soler J, Closas J, Pascual R, Planas J.
    Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
    [Abstract] [Full Text] [Related]

  • 25. Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension.
    Schwartz SL, Hanson C, Lucas C, Rosenblatt S, Rosenstock J, Whittier F, Wistran D, Riche C, Mulcahy WS.
    Clin Ther; 1993 Jun; 15(1):79-87. PubMed ID: 8458057
    [Abstract] [Full Text] [Related]

  • 26. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, Kivitz A, van Ingen H, Brabant T, Fort JG, Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators.
    Arch Intern Med; 2005 Jan 24; 165(2):161-8. PubMed ID: 15668361
    [Abstract] [Full Text] [Related]

  • 27. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ, Jaguste V, Nanivadekar AS.
    J Assoc Physicians India; 1998 Jan 24; Suppl 1():41-51. PubMed ID: 11233386
    [Abstract] [Full Text] [Related]

  • 28. A comparison of felodipine and nifedipine as monotherapies for the treatment of mild to moderate hypertension.
    Abelardo NS, Ramos EF, Mendoza VL, Sulit YQ, Mitchell MJ.
    J Hum Hypertens; 1989 Feb 24; 3(1):57-9. PubMed ID: 2657058
    [Abstract] [Full Text] [Related]

  • 29. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 24; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 30. Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.
    Saku K, Zhang B, Okamoto T, Takeda Y, Liu K, Jimi S, Arakawa K.
    J Hum Hypertens; 1996 Apr 24; 10(4):263-8. PubMed ID: 8736459
    [Abstract] [Full Text] [Related]

  • 31. Effectiveness and tolerability of once versus twice daily nitrendipine in the treatment of mild to moderate hypertension. The Canadian Nitrendipine Study Group.
    Bolli P, Cobby J, Handa SP, LaPlante LE, Mukherjee J, Rabin EZ, Strong HA, Wright JM.
    Can J Cardiol; 1991 Mar 24; 7(2):59-64. PubMed ID: 2049684
    [Abstract] [Full Text] [Related]

  • 32. Effect of captopril at two different dosage regimens in hypertensive non-insulin dependent patients.
    Escobar-Jiminez F, Fernandez Soto ML, Lobon JA, Aguilar M, Campos-Pastor MM, Garcia del Rio C.
    Postgrad Med J; 1988 Mar 24; 64 Suppl 3():65-8; discussion 90-2. PubMed ID: 3074299
    [Abstract] [Full Text] [Related]

  • 33. Antihypertensive efficacy and orthostatic tolerance of bunazosin vs nitrendipine: a multicentre double-blind randomized controlled study.
    Langenfeld MR, Bräutigam M, Weidinger G, Assmann I, Krönig B, Schmieder RE.
    J Hum Hypertens; 1996 Dec 24; 10(12):831-6. PubMed ID: 9140791
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of nitrendipine, 20 mg once daily in the management of hypertension in general practice.
    Ansquer JC, Boussac I, Triaud P.
    J Cardiovasc Pharmacol; 1991 Dec 24; 18 Suppl 1():S55-8. PubMed ID: 1723457
    [Abstract] [Full Text] [Related]

  • 35. Influence of therapy on silent ischemia and ventricular arrhythmias in hypertensive patients.
    Szlachcic J, Tubau JF, O'Kelly B, Ammon S, Massie BM.
    J Cardiovasc Pharmacol; 1991 Dec 24; 18 Suppl 1():S106-8. PubMed ID: 1723447
    [Abstract] [Full Text] [Related]

  • 36. Treatment of mild hypertension.
    Fodor JG, Chockalingam A.
    J Cardiovasc Pharmacol; 1991 Dec 24; 18 Suppl 1():S25-8; discussion S28-9. PubMed ID: 1723451
    [Abstract] [Full Text] [Related]

  • 37. Antihypertensive and metabolic effects of nitrendipine in non-insulin-dependent diabetes mellitus with hypertension.
    Giuntoli F, Galeone F, Natali A, Gabbani S, Saba P.
    J Cardiovasc Pharmacol; 1992 Dec 24; 19 Suppl 2():S39-40. PubMed ID: 1377303
    [Abstract] [Full Text] [Related]

  • 38. Comparative evaluation of the antihypertensive efficacy of once-daily amlodipine versus nitrendipine with 24-hour ambulatory blood pressure monitoring in essential hypertension.
    Coca A, Picado MJ, De la Sierra A, Aguilera MT, Sánchez M, Lluch MM, Urbano-Márquez A.
    J Cardiovasc Pharmacol; 1993 Oct 24; 22(4):513-8. PubMed ID: 7505351
    [Abstract] [Full Text] [Related]

  • 39. Cerebral blood flow is not altered by treatment with nitrendipine in patients with mild to moderate hypertension.
    Rüttimann S, Noll G, Dreifuss M, Müller-Brand J.
    J Cardiovasc Pharmacol; 1991 Oct 24; 18 Suppl 1():S109-11. PubMed ID: 1723448
    [Abstract] [Full Text] [Related]

  • 40. Once- vs. twice-daily nitrendipine in the treatment of mild to moderate hypertension, Canadian Nitrendipine Study Group.
    Bolli P, Cobby J, Handa SP, Laplante LE, Mukherjee J, Rabin EZ, Strong HA, Wright JM.
    J Cardiovasc Pharmacol; 1991 Oct 24; 17 Suppl 2():S182-5. PubMed ID: 1715478
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.